Loading…

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)

Low pulse pressure (PP) is associated with poor outcome in hospitalized patients with systolic heart failure (HF). However, the relation between PP and response to cardiac resynchronization therapy with defibrillator (CRT-D) is unknown. We aimed to evaluate the relation between preimplantation PP an...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of cardiology 2014-10, Vol.114 (7), p.1053-1058
Main Authors: Sherazi, Saadia, MD, MS, Goldenberg, Ilan, MD, Moss, Arthur J., MD, Solomon, Scott, MD, Kutyifa, Valentina, MD, PhD, McNitt, Scott, MS, Shah, Abrar H., MD, Huang, David T., MD, Aktas, Mehmet K., MD, Zareba, Wojciech, MD, PhD, Barsheshet, Alon, MD
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63
cites cdi_FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63
container_end_page 1058
container_issue 7
container_start_page 1053
container_title The American journal of cardiology
container_volume 114
creator Sherazi, Saadia, MD, MS
Goldenberg, Ilan, MD
Moss, Arthur J., MD
Solomon, Scott, MD
Kutyifa, Valentina, MD, PhD
McNitt, Scott, MS
Shah, Abrar H., MD
Huang, David T., MD
Aktas, Mehmet K., MD
Zareba, Wojciech, MD, PhD
Barsheshet, Alon, MD
description Low pulse pressure (PP) is associated with poor outcome in hospitalized patients with systolic heart failure (HF). However, the relation between PP and response to cardiac resynchronization therapy with defibrillator (CRT-D) is unknown. We aimed to evaluate the relation between preimplantation PP and echocardiographic response to CRT-D and subsequent clinical outcome after 1 year. The relation between preimplantation PP and echocardiographic response to CRT-D (defined as >15% reduction in left ventricular (LV) end-systolic volume at 1 year) was evaluated in 754 patients with CRT-D with left bundle branch block enrolled in Multicenter Automatic Defibrillator Cardioverter Defibrillator Implantation Trial-Cardiac Resynchronization Therapy. The association between PP at 1 year and the risk for subsequent HF or death was evaluated using multivariate Cox model. Patients with high versus low PP (>40 vs ≤40 mm Hg [lower quartile]) had a significantly greater reduction in LV end-systolic volume, LV end-diastolic volume, and LV dyssynchrony (p lower quartile) 1 year after CRT-D implantation experienced a 50% reduction in the risk of subsequent HF or death (p = 0.001) and 63% reduction in death only (p = 0.001), compared with patients with low PP. In conclusion, high baseline PP is an independent predictor of echocardiographic response to CRT-D, and high PP after device implantation is associated with improved subsequent clinical outcome.
doi_str_mv 10.1016/j.amjcard.2014.07.014
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1561969414</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002914914014428</els_id><sourcerecordid>1561969414</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63</originalsourceid><addsrcrecordid>eNqFks1uEzEQx1cIREPhEUCWuKSHDZ793ktRSSmpFEQFhavlnZ1tHHbXwfYWhafhWXgj3gBvEkDqpaexpf_85usfBM-Bz4BD9mo9k90apalnEYdkxvOZDw-CCRR5GUIJ8cNgwjmPwhKS8ih4Yu3afwHS7HFwFKUABUA2CX7PdbeRRlndM92wpf7OvpCxg2ULdbNi09OE__rZdWxxc8KuhtYSuzJk7WCIOT2-a4WOuRWxN9RTo9xImfu2lET2key2x5XRvfohnfIlrldk5GbLGm3YgqRx7EKqdqRNG6O7Hej90DqF1Dsy7GxwuvOpyM49vDKqbaXzuZfdppW9O0CNkm14f9Gd7uRp8KiRfpBnh3gcfL54ez1fhMsP7y7nZ8sQUyhciDmPq4InkV8UJYBNDHWMScURogjimFIsCTJZ1VFRRBlRIjOsMMcSK5lWWXwcTPfcjdHfBrJOdMoi-QF60oMV_hJQZmUCiZe-vCNd68H0vjsBGaR5kUfFCEz3KjTaWkON2BjVSbMVwMXoCbEWB0-I0ROC54Lv6C8O9KHqqP6X9dcEXvB6LyC_jltFRlhU1KO_rSF0otbq3hKndwjYql6hbL_Sluz_aYSNBBefRmOOvoTEZydREf8Bd2LkGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1615787286</pqid></control><display><type>article</type><title>Comparison of Low Versus High (&gt;40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)</title><source>Elsevier</source><creator>Sherazi, Saadia, MD, MS ; Goldenberg, Ilan, MD ; Moss, Arthur J., MD ; Solomon, Scott, MD ; Kutyifa, Valentina, MD, PhD ; McNitt, Scott, MS ; Shah, Abrar H., MD ; Huang, David T., MD ; Aktas, Mehmet K., MD ; Zareba, Wojciech, MD, PhD ; Barsheshet, Alon, MD</creator><creatorcontrib>Sherazi, Saadia, MD, MS ; Goldenberg, Ilan, MD ; Moss, Arthur J., MD ; Solomon, Scott, MD ; Kutyifa, Valentina, MD, PhD ; McNitt, Scott, MS ; Shah, Abrar H., MD ; Huang, David T., MD ; Aktas, Mehmet K., MD ; Zareba, Wojciech, MD, PhD ; Barsheshet, Alon, MD</creatorcontrib><description>Low pulse pressure (PP) is associated with poor outcome in hospitalized patients with systolic heart failure (HF). However, the relation between PP and response to cardiac resynchronization therapy with defibrillator (CRT-D) is unknown. We aimed to evaluate the relation between preimplantation PP and echocardiographic response to CRT-D and subsequent clinical outcome after 1 year. The relation between preimplantation PP and echocardiographic response to CRT-D (defined as &gt;15% reduction in left ventricular (LV) end-systolic volume at 1 year) was evaluated in 754 patients with CRT-D with left bundle branch block enrolled in Multicenter Automatic Defibrillator Cardioverter Defibrillator Implantation Trial-Cardiac Resynchronization Therapy. The association between PP at 1 year and the risk for subsequent HF or death was evaluated using multivariate Cox model. Patients with high versus low PP (&gt;40 vs ≤40 mm Hg [lower quartile]) had a significantly greater reduction in LV end-systolic volume, LV end-diastolic volume, and LV dyssynchrony (p &lt;0.01 for all comparisons). In multivariate analysis, the presence of high PP was associated with a 3.5-fold (p &lt;0.001) increase in the likelihood of a positive echocardiographic response to CRT-D. Patients with high PP (&gt;40 mm Hg, &gt;lower quartile) 1 year after CRT-D implantation experienced a 50% reduction in the risk of subsequent HF or death (p = 0.001) and 63% reduction in death only (p = 0.001), compared with patients with low PP. In conclusion, high baseline PP is an independent predictor of echocardiographic response to CRT-D, and high PP after device implantation is associated with improved subsequent clinical outcome.</description><identifier>ISSN: 0002-9149</identifier><identifier>EISSN: 1879-1913</identifier><identifier>DOI: 10.1016/j.amjcard.2014.07.014</identifier><identifier>PMID: 25118116</identifier><identifier>CODEN: AJCDAG</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Blood pressure ; Blood Pressure - physiology ; Cardiac Resynchronization Therapy - methods ; Cardiovascular ; Cause of Death - trends ; Defibrillators, Implantable ; Drug therapy ; Echocardiography ; Electrocardiography ; Equipment Design ; Female ; Follow-Up Studies ; Heart attacks ; Heart Failure - mortality ; Heart Failure - physiopathology ; Heart Failure - therapy ; Heart Ventricles - diagnostic imaging ; Heart Ventricles - physiopathology ; Humans ; Israel - epidemiology ; Male ; Middle Aged ; Older people ; Risk Factors ; Stroke Volume ; Survival Rate - trends ; Treatment Outcome ; United States - epidemiology ; Ventricular Function, Left - physiology</subject><ispartof>The American journal of cardiology, 2014-10, Vol.114 (7), p.1053-1058</ispartof><rights>Elsevier Inc.</rights><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Oct 1, 2014</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63</citedby><cites>FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25118116$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sherazi, Saadia, MD, MS</creatorcontrib><creatorcontrib>Goldenberg, Ilan, MD</creatorcontrib><creatorcontrib>Moss, Arthur J., MD</creatorcontrib><creatorcontrib>Solomon, Scott, MD</creatorcontrib><creatorcontrib>Kutyifa, Valentina, MD, PhD</creatorcontrib><creatorcontrib>McNitt, Scott, MS</creatorcontrib><creatorcontrib>Shah, Abrar H., MD</creatorcontrib><creatorcontrib>Huang, David T., MD</creatorcontrib><creatorcontrib>Aktas, Mehmet K., MD</creatorcontrib><creatorcontrib>Zareba, Wojciech, MD, PhD</creatorcontrib><creatorcontrib>Barsheshet, Alon, MD</creatorcontrib><title>Comparison of Low Versus High (&gt;40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)</title><title>The American journal of cardiology</title><addtitle>Am J Cardiol</addtitle><description>Low pulse pressure (PP) is associated with poor outcome in hospitalized patients with systolic heart failure (HF). However, the relation between PP and response to cardiac resynchronization therapy with defibrillator (CRT-D) is unknown. We aimed to evaluate the relation between preimplantation PP and echocardiographic response to CRT-D and subsequent clinical outcome after 1 year. The relation between preimplantation PP and echocardiographic response to CRT-D (defined as &gt;15% reduction in left ventricular (LV) end-systolic volume at 1 year) was evaluated in 754 patients with CRT-D with left bundle branch block enrolled in Multicenter Automatic Defibrillator Cardioverter Defibrillator Implantation Trial-Cardiac Resynchronization Therapy. The association between PP at 1 year and the risk for subsequent HF or death was evaluated using multivariate Cox model. Patients with high versus low PP (&gt;40 vs ≤40 mm Hg [lower quartile]) had a significantly greater reduction in LV end-systolic volume, LV end-diastolic volume, and LV dyssynchrony (p &lt;0.01 for all comparisons). In multivariate analysis, the presence of high PP was associated with a 3.5-fold (p &lt;0.001) increase in the likelihood of a positive echocardiographic response to CRT-D. Patients with high PP (&gt;40 mm Hg, &gt;lower quartile) 1 year after CRT-D implantation experienced a 50% reduction in the risk of subsequent HF or death (p = 0.001) and 63% reduction in death only (p = 0.001), compared with patients with low PP. In conclusion, high baseline PP is an independent predictor of echocardiographic response to CRT-D, and high PP after device implantation is associated with improved subsequent clinical outcome.</description><subject>Aged</subject><subject>Blood pressure</subject><subject>Blood Pressure - physiology</subject><subject>Cardiac Resynchronization Therapy - methods</subject><subject>Cardiovascular</subject><subject>Cause of Death - trends</subject><subject>Defibrillators, Implantable</subject><subject>Drug therapy</subject><subject>Echocardiography</subject><subject>Electrocardiography</subject><subject>Equipment Design</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart attacks</subject><subject>Heart Failure - mortality</subject><subject>Heart Failure - physiopathology</subject><subject>Heart Failure - therapy</subject><subject>Heart Ventricles - diagnostic imaging</subject><subject>Heart Ventricles - physiopathology</subject><subject>Humans</subject><subject>Israel - epidemiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Older people</subject><subject>Risk Factors</subject><subject>Stroke Volume</subject><subject>Survival Rate - trends</subject><subject>Treatment Outcome</subject><subject>United States - epidemiology</subject><subject>Ventricular Function, Left - physiology</subject><issn>0002-9149</issn><issn>1879-1913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqFks1uEzEQx1cIREPhEUCWuKSHDZ793ktRSSmpFEQFhavlnZ1tHHbXwfYWhafhWXgj3gBvEkDqpaexpf_85usfBM-Bz4BD9mo9k90apalnEYdkxvOZDw-CCRR5GUIJ8cNgwjmPwhKS8ih4Yu3afwHS7HFwFKUABUA2CX7PdbeRRlndM92wpf7OvpCxg2ULdbNi09OE__rZdWxxc8KuhtYSuzJk7WCIOT2-a4WOuRWxN9RTo9xImfu2lET2key2x5XRvfohnfIlrldk5GbLGm3YgqRx7EKqdqRNG6O7Hej90DqF1Dsy7GxwuvOpyM49vDKqbaXzuZfdppW9O0CNkm14f9Gd7uRp8KiRfpBnh3gcfL54ez1fhMsP7y7nZ8sQUyhciDmPq4InkV8UJYBNDHWMScURogjimFIsCTJZ1VFRRBlRIjOsMMcSK5lWWXwcTPfcjdHfBrJOdMoi-QF60oMV_hJQZmUCiZe-vCNd68H0vjsBGaR5kUfFCEz3KjTaWkON2BjVSbMVwMXoCbEWB0-I0ROC54Lv6C8O9KHqqP6X9dcEXvB6LyC_jltFRlhU1KO_rSF0otbq3hKndwjYql6hbL_Sluz_aYSNBBefRmOOvoTEZydREf8Bd2LkGQ</recordid><startdate>20141001</startdate><enddate>20141001</enddate><creator>Sherazi, Saadia, MD, MS</creator><creator>Goldenberg, Ilan, MD</creator><creator>Moss, Arthur J., MD</creator><creator>Solomon, Scott, MD</creator><creator>Kutyifa, Valentina, MD, PhD</creator><creator>McNitt, Scott, MS</creator><creator>Shah, Abrar H., MD</creator><creator>Huang, David T., MD</creator><creator>Aktas, Mehmet K., MD</creator><creator>Zareba, Wojciech, MD, PhD</creator><creator>Barsheshet, Alon, MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7Z</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20141001</creationdate><title>Comparison of Low Versus High (&gt;40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)</title><author>Sherazi, Saadia, MD, MS ; Goldenberg, Ilan, MD ; Moss, Arthur J., MD ; Solomon, Scott, MD ; Kutyifa, Valentina, MD, PhD ; McNitt, Scott, MS ; Shah, Abrar H., MD ; Huang, David T., MD ; Aktas, Mehmet K., MD ; Zareba, Wojciech, MD, PhD ; Barsheshet, Alon, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Aged</topic><topic>Blood pressure</topic><topic>Blood Pressure - physiology</topic><topic>Cardiac Resynchronization Therapy - methods</topic><topic>Cardiovascular</topic><topic>Cause of Death - trends</topic><topic>Defibrillators, Implantable</topic><topic>Drug therapy</topic><topic>Echocardiography</topic><topic>Electrocardiography</topic><topic>Equipment Design</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart attacks</topic><topic>Heart Failure - mortality</topic><topic>Heart Failure - physiopathology</topic><topic>Heart Failure - therapy</topic><topic>Heart Ventricles - diagnostic imaging</topic><topic>Heart Ventricles - physiopathology</topic><topic>Humans</topic><topic>Israel - epidemiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Older people</topic><topic>Risk Factors</topic><topic>Stroke Volume</topic><topic>Survival Rate - trends</topic><topic>Treatment Outcome</topic><topic>United States - epidemiology</topic><topic>Ventricular Function, Left - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sherazi, Saadia, MD, MS</creatorcontrib><creatorcontrib>Goldenberg, Ilan, MD</creatorcontrib><creatorcontrib>Moss, Arthur J., MD</creatorcontrib><creatorcontrib>Solomon, Scott, MD</creatorcontrib><creatorcontrib>Kutyifa, Valentina, MD, PhD</creatorcontrib><creatorcontrib>McNitt, Scott, MS</creatorcontrib><creatorcontrib>Shah, Abrar H., MD</creatorcontrib><creatorcontrib>Huang, David T., MD</creatorcontrib><creatorcontrib>Aktas, Mehmet K., MD</creatorcontrib><creatorcontrib>Zareba, Wojciech, MD, PhD</creatorcontrib><creatorcontrib>Barsheshet, Alon, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest research library</collection><collection>Biochemistry Abstracts 1</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sherazi, Saadia, MD, MS</au><au>Goldenberg, Ilan, MD</au><au>Moss, Arthur J., MD</au><au>Solomon, Scott, MD</au><au>Kutyifa, Valentina, MD, PhD</au><au>McNitt, Scott, MS</au><au>Shah, Abrar H., MD</au><au>Huang, David T., MD</au><au>Aktas, Mehmet K., MD</au><au>Zareba, Wojciech, MD, PhD</au><au>Barsheshet, Alon, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of Low Versus High (&gt;40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)</atitle><jtitle>The American journal of cardiology</jtitle><addtitle>Am J Cardiol</addtitle><date>2014-10-01</date><risdate>2014</risdate><volume>114</volume><issue>7</issue><spage>1053</spage><epage>1058</epage><pages>1053-1058</pages><issn>0002-9149</issn><eissn>1879-1913</eissn><coden>AJCDAG</coden><abstract>Low pulse pressure (PP) is associated with poor outcome in hospitalized patients with systolic heart failure (HF). However, the relation between PP and response to cardiac resynchronization therapy with defibrillator (CRT-D) is unknown. We aimed to evaluate the relation between preimplantation PP and echocardiographic response to CRT-D and subsequent clinical outcome after 1 year. The relation between preimplantation PP and echocardiographic response to CRT-D (defined as &gt;15% reduction in left ventricular (LV) end-systolic volume at 1 year) was evaluated in 754 patients with CRT-D with left bundle branch block enrolled in Multicenter Automatic Defibrillator Cardioverter Defibrillator Implantation Trial-Cardiac Resynchronization Therapy. The association between PP at 1 year and the risk for subsequent HF or death was evaluated using multivariate Cox model. Patients with high versus low PP (&gt;40 vs ≤40 mm Hg [lower quartile]) had a significantly greater reduction in LV end-systolic volume, LV end-diastolic volume, and LV dyssynchrony (p &lt;0.01 for all comparisons). In multivariate analysis, the presence of high PP was associated with a 3.5-fold (p &lt;0.001) increase in the likelihood of a positive echocardiographic response to CRT-D. Patients with high PP (&gt;40 mm Hg, &gt;lower quartile) 1 year after CRT-D implantation experienced a 50% reduction in the risk of subsequent HF or death (p = 0.001) and 63% reduction in death only (p = 0.001), compared with patients with low PP. In conclusion, high baseline PP is an independent predictor of echocardiographic response to CRT-D, and high PP after device implantation is associated with improved subsequent clinical outcome.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25118116</pmid><doi>10.1016/j.amjcard.2014.07.014</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0002-9149
ispartof The American journal of cardiology, 2014-10, Vol.114 (7), p.1053-1058
issn 0002-9149
1879-1913
language eng
recordid cdi_proquest_miscellaneous_1561969414
source Elsevier
subjects Aged
Blood pressure
Blood Pressure - physiology
Cardiac Resynchronization Therapy - methods
Cardiovascular
Cause of Death - trends
Defibrillators, Implantable
Drug therapy
Echocardiography
Electrocardiography
Equipment Design
Female
Follow-Up Studies
Heart attacks
Heart Failure - mortality
Heart Failure - physiopathology
Heart Failure - therapy
Heart Ventricles - diagnostic imaging
Heart Ventricles - physiopathology
Humans
Israel - epidemiology
Male
Middle Aged
Older people
Risk Factors
Stroke Volume
Survival Rate - trends
Treatment Outcome
United States - epidemiology
Ventricular Function, Left - physiology
title Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T02%3A52%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20Low%20Versus%20High%20(%3E40%C2%A0mm%20Hg)%20Pulse%20Pressure%20to%20Predict%20the%20Benefit%20of%20Cardiac%20Resynchronization%20Therapy%20for%20Heart%20Failure%20(from%20the%20Multicenter%20Automatic%20Defibrillator%20Implantation%20Trial-Cardiac%20Resynchronization%20Therapy%20Trial)&rft.jtitle=The%20American%20journal%20of%20cardiology&rft.au=Sherazi,%20Saadia,%20MD,%20MS&rft.date=2014-10-01&rft.volume=114&rft.issue=7&rft.spage=1053&rft.epage=1058&rft.pages=1053-1058&rft.issn=0002-9149&rft.eissn=1879-1913&rft.coden=AJCDAG&rft_id=info:doi/10.1016/j.amjcard.2014.07.014&rft_dat=%3Cproquest_cross%3E1561969414%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c518t-c703b8042181e41cf31d3c4b0c122133e5c9e16abd28826ee4a6cbc7c9cba5b63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1615787286&rft_id=info:pmid/25118116&rfr_iscdi=true